Literature DB >> 9764611

Apoptosis in labial salivary glands from Sjögren's syndrome (SS) patients: comparison with human T lymphotropic virus-I (HTLV-I)-seronegative and -seropositive SS patients.

H Nakamura1, T Koji, M Tominaga, A Kawakami, K Migita, Y Kawabe, T Nakamura, S Shirabe, K Eguchi.   

Abstract

Apoptosis is a type of cell death that occurs during morphogenesis and development of the immune system. One of the mechanisms is mediated through the Fas and Fas ligand (FasL) pathway. To determine the possible involvement of Fas and its ligand in salivary gland destruction, we analysed the appearance of nuclei with DNA fragmentation by using nick end labelling (TUNEL) and the expression of Fas and FasL by immunohistochemistry in labial salivary glands. Furthermore, we compared the features of apoptosis in labial salivary glands between HTLV-I- and HTLV-I+ SS. When the frozen sections of 10 primary SS patients in the absence of anti-HTLV-I antibody were examined, several apoptotic cells were found in the acinar and ductal epithelial cells as well as infiltrated mononuclear cells. Both Fas and FasL were detected in the infiltrated mononuclear cells. Acinar epithelial cells, which are surrounded by FasL+ mononuclear cells, were also double-positive with Fas and FasL, although the expression of FasL was localized at their apical border, suggesting that apoptosis of mononuclear cells was achieved by activation-induced mechanisms through Fas/FasL pathways, and that of acinar epithelial cells was mediated by FasL derived from either acinar epithelial cells themselves or infiltrated mononuclear cells. Interestingly, Fas expression in ductal epithelial cells was localized around the lumen side of the ducts, indicating that FasL secreted from acinar epithelial cells may induce Fas-mediated apoptosis of ductal epithelial cells. We also studied the labial salivary glands from nine SS patients with anti-HTLV-I antibodies. There was no significant difference in the occurrence of apoptotic cells or in the expression of Fas and FasL between HTLV-I+ and HTLV-I- SS patients. It was of note that neither the expression of Fas and FasL nor the presence of apoptotic cells were determined in labial salivary glands from subjects without SS. These findings indicate that Fas-mediated apoptosis in salivary glands could be involved in the pathological manifestations of SS, irrespective of HTLV-I seropositivity.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9764611      PMCID: PMC1905091          DOI: 10.1046/j.1365-2249.1998.00692.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  22 in total

1.  High prevalence of Sjögren's syndrome in patients with HTLV-I associated myelopathy.

Authors:  H Nakamura; K Eguchi; T Nakamura; A Mizokami; S Shirabe; A Kawakami; N Matsuoka; K Migita; Y Kawabe; S Nagataki
Journal:  Ann Rheum Dis       Date:  1997-03       Impact factor: 19.103

2.  Primary Sjögren's syndrome with antibodies to HTLV-I: clinical and laboratory features.

Authors:  K Eguchi; N Matsuoka; H Ida; M Nakashima; M Sakai; S Sakito; A Kawakami; K Terada; H Shimada; Y Kawabe
Journal:  Ann Rheum Dis       Date:  1992-06       Impact factor: 19.103

3.  Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family.

Authors:  T Suda; T Takahashi; P Golstein; S Nagata
Journal:  Cell       Date:  1993-12-17       Impact factor: 41.582

4.  Exocrinopathy resembling Sjögren's syndrome in HTLV-1 tax transgenic mice.

Authors:  J E Green; S H Hinrichs; J Vogel; G Jay
Journal:  Nature       Date:  1989-09-07       Impact factor: 49.962

5.  Preliminary criteria for the classification of Sjögren's syndrome. Results of a prospective concerted action supported by the European Community.

Authors:  C Vitali; S Bombardieri; H M Moutsopoulos; G Balestrieri; W Bencivelli; R M Bernstein; K B Bjerrum; S Braga; J Coll; S de Vita
Journal:  Arthritis Rheum       Date:  1993-03

6.  Immunohistologic analysis of lymphoid infiltrates in primary Sjogren's syndrome using monoclonal antibodies.

Authors:  T C Adamson; R I Fox; D M Frisman; F V Howell
Journal:  J Immunol       Date:  1983-01       Impact factor: 5.422

7.  The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis.

Authors:  N Itoh; S Yonehara; A Ishii; M Yonehara; S Mizushima; M Sameshima; A Hase; Y Seto; S Nagata
Journal:  Cell       Date:  1991-07-26       Impact factor: 41.582

8.  Increased epithelial expression of HLA-DQ and HLA-DP molecules in salivary glands from patients with Sjögren's syndrome compared with obstructive sialadenitis.

Authors:  P S Thrane; T S Halstensen; H R Haanaes; P Brandtzaeg
Journal:  Clin Exp Immunol       Date:  1993-05       Impact factor: 4.330

9.  Identification and functional characterization of a TIA-1-related nucleolysin.

Authors:  A Kawakami; Q Tian; X Duan; M Streuli; S F Schlossman; P Anderson
Journal:  Proc Natl Acad Sci U S A       Date:  1992-09-15       Impact factor: 11.205

10.  Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation.

Authors:  Y Gavrieli; Y Sherman; S A Ben-Sasson
Journal:  J Cell Biol       Date:  1992-11       Impact factor: 10.539

View more
  13 in total

Review 1.  Immunopathogenesis of Sjögren's syndrome.

Authors:  Andrea T Borchers; Stanley M Naguwa; Carl L Keen; M Eric Gershwin
Journal:  Clin Rev Allergy Immunol       Date:  2003-08       Impact factor: 8.667

2.  Fas-Fas ligand system as a possible mediator of spermatogenic cell apoptosis in human maturation-arrested testes.

Authors:  Jiro Eguchi; Takehiko Koji; Koichiro Nomata; Akira Yoshii; Masashi Shin; Hiroshi Kanetake
Journal:  Hum Cell       Date:  2002-03       Impact factor: 4.174

3.  ALX/FPR2 receptor for RvD1 is expressed and functional in salivary glands.

Authors:  Joel W Nelson; Noel J Leigh; Rachel E Mellas; Andrew D McCall; Alfredo Aguirre; Olga J Baker
Journal:  Am J Physiol Cell Physiol       Date:  2013-11-20       Impact factor: 4.249

4.  Detection of apoptosis-specific autoantibodies directed against granzyme B-induced cleavage fragments of the SS-B (La) autoantigen in sera from patients with primary Sjögren's syndrome.

Authors:  M Huang; H Ida; M Kamachi; N Iwanaga; Y Izumi; F Tanaka; K Aratake; K Arima; M Tamai; A Hida; H Nakamura; T Origuchi; A Kawakami; N Ogawa; S Sugai; P J Utz; K Eguchi
Journal:  Clin Exp Immunol       Date:  2005-10       Impact factor: 4.330

5.  TLR3-mediated apoptosis and activation of phosphorylated Akt in the salivary gland epithelial cells of primary Sjögren's syndrome patients.

Authors:  Hideki Nakamura; Yoshiro Horai; Takahisa Suzuki; Akitomo Okada; Kunihiro Ichinose; Satoshi Yamasaki; Takehiko Koji; Atsushi Kawakami
Journal:  Rheumatol Int       Date:  2012-03-29       Impact factor: 2.631

6.  Fas/FasL mediated apoptosis of thyrocytes in Graves' disease.

Authors:  N Sera; A Kawakami; T Nakashima; H Nakamura; M Imaizumi; T Koji; Y Abe; T Usa; T Tominaga; E Ejima; K Ashizawa; N Yokoyama; N Ishikawa; K Ito; K Eguchi
Journal:  Clin Exp Immunol       Date:  2001-05       Impact factor: 4.330

7.  Expression of cyclooxygenase-1 (COX-1) in labial salivary glands of Sjögren's syndrome.

Authors:  M Tominaga; K Migita; H Sano; W Fukui; M Kohno; Y Tsubouchi; S Honda; T Fukuda; H Nakamura; S Yamasaki; Y Kawabe; A Kawakami; K Eguchi
Journal:  Clin Exp Immunol       Date:  2000-12       Impact factor: 4.330

8.  Involvement of Fas/Fas ligand in the induction of apoptosis in chronic sialadenitis of minor salivary glands including Sjögren's syndrome.

Authors:  Yasuaki Shibata; Yoshitaka Hishikawa; Shinichi Izumi; Shuichi Fujita; Akira Yamaguchi; Takehiko Koji
Journal:  Hum Cell       Date:  2002-03       Impact factor: 4.174

9.  Abnormal expression and function of Fas ligand of lacrimal glands and peripheral blood in Sjögren's syndrome patients with enlarged exocrine glands.

Authors:  K Tsubota; H Fujita; K Tadano; N Onoda; K Tsuzaka; T Takeuchi
Journal:  Clin Exp Immunol       Date:  2002-07       Impact factor: 4.330

10.  EGF activates PI3K-Akt and NF-kappaB via distinct pathways in salivary epithelial cells in Sjögren's syndrome.

Authors:  Hideki Nakamura; Atsushi Kawakami; Hiroaki Ida; Takehiko Koji; Katsumi Eguchi
Journal:  Rheumatol Int       Date:  2007-07-20       Impact factor: 2.631

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.